TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience

BACKGROUND: Hepatocellular carcinoma (HCC) with symptomatic portal hypertension (SPH) has poor prognosis. A transjugular intrahepatic portosystemic shunt (TIPS) relieves SPH, but its application in HCC remains unclear. We evaluated TIPS efficacy in patients with HCC and SPH. METHODS: Pre- and post-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Huzheng, Qiu, Zhenkang, Xiang, Zhanwang, Feng, Kai, Huang, Mingsheng, Gao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858571/
https://www.ncbi.nlm.nih.gov/pubmed/35183265
http://dx.doi.org/10.1186/s40644-022-00451-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858571/
https://www.ncbi.nlm.nih.gov/pubmed/35183265
http://dx.doi.org/10.1186/s40644-022-00451-9

Ejemplares similares